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1. Introdliction 
The recent identification of RNA dependent DNA 
polymerase in acute leukemic cells from humans [ 1 ] 
leads to the question of whether the polymerase is 
present in other mammalian leukemic cells, particu- 
larly those available in large quantities from tissue 
culture. The initial finding of an RNA dependent 
DNA polymerase in oncogenic RNA viruses [2-61 and 
the presence of the polymerase in human leukemic 
cells provide a basis for gene amplification and leukemo- 
genesis. The present study reports on the characteristics 
of an RNA dependent DNA polymerase from L5 178Y 
leukemic mouse cells. In addition the activity of the en- 
zyme in a synchronous population was studied to de- 
termine whether the enzyme is active during the nor- 
mal DNA synthesis (S) period or at other times in the 
cell cycle. 
2. Materials and methods 
Cells were cultured in Fischer’s medium [7] plus 
10% horse serum as previously described [8] . Cells 
were synchronized by the method of Doida and Okada 
[9] as described previously. Details of synchrony and 
cell parameters are given in previous publications [lo- 
131. 
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Table 1 
Characteristics of L5178Y RNA dependent DNA polymerase. 
System cpmlassay 
Complete 2492 
0’ (incubate) 361 
0 time (immediate termination) 0 
minus ‘enzyme’ 0 
minus ‘enzyme’ plus boiled ‘enzyme’ 29 
minus ‘template’ 0 
minus ‘template’ plus RNase treated ‘template’ 116 
minus ‘template’ plus DNase treated ‘template’ 2362 
Product: DNase treated 311 
Product: RNase treated 2396 
Product: 0.5 N NaOH 2118 
minus dATP, dCTP, dGTP 416 
minus MgClz 304 
minus ‘template’ plus yeast RNA 393 
incubate 1 hr 37O 1119 
minus TTP-3H plus 5 @Zi TTP-3H 1546 
The complete system contained in a final volume of 1 ml the 
following: 0.50 mg protein from the ‘nucleic acid free’ extract 
(‘enzyme’); 1.0 rmole each of dATP, sCTP, and dGTP; 50 
pmoles tris-HCl buffer pH 8.4; 5.0 @moles hlgC1,; 10 PCi 
3H-methyl TTP (7 Ci/mmole, New England Nuclear); 20 
pmoles dithiothreitol; 50 flmoles NaCl; and 36 fig of rat liver 
RNA (‘template’), Assays were incubated at 37’ for 2 hr, 
after which 1 mg of yeast RNA was added and the assay was 
made 10% in trichloroacetic acid. The resultant precipitates 
were washed 3 times with 10% trichloroacetic acid, dissolved 
in 1 N NaOH at loo’, plated on a glass fiber filter and counted 
in a liquid scintillation counter. Rat liver RNA (‘template’) 
was purchased from General Biochemicals and treated with 
DNase and the enzyme removed by phenol extraction. DNase 
and RNase were present at 4 mg per ml and were purchased 
from Worthington. All data are given with endogenous ac- 
tivity (about 10%) determined with water substituted for the 
‘template’ subtracted. Yeast RNA was purchased from Worth- 
ington and was present at 36 mg per assay. 
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A ‘nucleic acid free extract’ was prepared essential- 
ly as described by Gallo et al. [l] . Exponential 
L5 178Y cells or synchronized L5 178Y cells taken at 
one half hour intervals from a synchronous population 
were vigorously homogenized for 30 strokes in a Pot- 
ter Elvehjem homogenizer at 0”. The homogenizing 
solution was 5 volumes of 25 mM tris-HCl buffer pH 
8.3, 1 mM MgClz ,6 mM NaCl, 5 mM dithiothreitol 
and 0.15 mM EDTA. The samples were centrifuged 
at 27,000 g and the pellet discarded. Nucleic acids 
were removed from the supernatant by successive pre- 
cipitations with MnCl, and protamine sulfate. This 
crude preparation was utilized as the enzyme source in 
this report. Details of the enzyme assay are given in the 
legend to table 1. A crude 0.1% Triton X-100 extract of 
the L5 178Y cells also exhibited RNA dependent DNA 
polymerase activity but the endogenous activity due to 
DNA template in the extract was prohibitively high. 
All biochemicals not specifically mentioned were ob- 
tained in the purest available form from usual sources. 
Degree of synchrony was measured utilizing ’ H-thymi- 
dine and cell number counts determined with a Coulter 
Counter as previously described [lo- 131. 
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Fig. 1. RNA dependent DNA polymerase activity in a synchro- 
nized L5178Y cell population. At 0 hr the cells were released 
from the mitotic block. At each successive one-half hour the cells 
were assayed for RNA dependent DNA polymerase. At each one- 
half hour a ‘nucleic acid free extract’ was prepared as given in 
Materials and methods. The assay was exactly as given in the leg- 
end to table 1. Above the graph is a representation of the cell 
cycle. Each point is the mean of three observations. 
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3. Results and discussion 
The data in table 1 indicate that L5 178Y mouse 
leukemic cells possess an RNA dependent DNA poly- 
merase. The enzyme is dependent on RNA as a tem- 
plate as evidenced by the low activity found with RNase 
treated template and the high activity found with 
DNase treated template. That the product is DNA, . 
is evidenced by the lack of degradation by RNase, 
degradation by DNase, trichloroacetic acid insolubility, 
and alkali resistance (table 1). The reaction is depen- 
dent on Mg2’ and dATP, dCTP and dGTP. Unlike the 
human cell polymerase [ 1 ] the enzyme seems relat- 
ively specific for mammalian RNA since yeast RNA 
was relatively ineffective as a template. 
The data in fig. 1 indicate that the RNA depen- 
dent DNA polymerase is a continuous enzyme in the 
synchronous L5 178Y cell population as opposed to 
a step or peak enzyme [ 141. DNA dependent DNA 
polymerase has been described as a peak enzyme in 
Sacharomyces cerevisiue [ 151, a continuous [ 161 or 
a peak enzyme [ 171 in mouse L cells, and a peak en- 
zyme [ 181 in HeLa cells. The RNA dependent DNA 
polymerase is active throughout the cell cycle and 
not active only in the S period; indeed the highest 
activity occurs at 9.5 hr post mitosis in the early M 
period. 
The results indicate that the RNA dependent DNA 
polymerase is active throughout the cell cycle and there- 
fore would be present for information transfer from 
RNA viruses or for gene amplification. The presence 
of the polymerase in mouse leukemic cells does not 
indicate a direct relationship to viral leukemogenesis 
but is consistent with a viral etiology. The fact that 
the enzyme is present in mouse leukemic cells and is 
active throughout the cell cycle points to the fact that 
it may be coded for by the host cell DNA. The occurrence 
of the polymerase in tissue culture cells provides a con- 
venient source for purification and study of the en- 
zyme and its implications. 
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